Isoflurane anesthetic (see Discussion) Isotonic saline (sterile) Mice from GEMM of interest
This protocol uses the KrasLSL.G12D/+;p53R172H/+;PdxCre (KPC) model of pancreatic ductal adenocarcinoma as an example for demonstration purposes. Before using this protocol, it is important to become familiar with several concepts pertaining to the biopsy surgery, including anesthesia and tumor localization (see Discussion for further detail).
Ophthalmic ointment Tissue treatment reagents, as needed (e.g., formalin, liquid nitrogen, OCT, RNAlater, etc.)
Equipment
Cleaning wipes (e.g., Kimwipes) Cotton tip applicators (sterile) Gauze sponges Imaging instrumentation for preprocedure assessment (VisualSonics Vevo 2100 high-resolution ultrasound with color Doppler feature) Medical air or oxygen supply Microcentrifuge tubes or cryotubes for samples Needle (27 gauge) Surgical equipment Anesthesia induction chamber fitted with a waste-gas scavenging system Animal clippers (handheld) with a fine blade Biometric system for real-time monitoring of animal vital signs (heart rate, respiration rate, core body temperature, pulse oximetry)
Biometric monitoring can include a rectal thermometer or thermocouple for core body temperature monitoring, pulse oximetry using a footpad clip sensor, and/or ECG measurement via footpad electrode connections.
Biopsy forceps
Micro biopsy forceps are a custom-made surgical instrument constructed for the purpose of firmly clamping the tumor while allowing extraction of a cylindrical core biopsy with a small diameter biopsy punch (Fig. 1) . The instrument may be fabricated in a machine shop or modified from a commercially available Singley organ holding forceps (e.g., Roboz Instruments RS-5255). Two modifications are made to the Singley forceps. First, the aperture on one side of the forceps is filled in or replaced with a flat, finely serrated plate. This allows the forceps to grip the tumor firmly and provides a cutting surface for the biopsy punch to abut. Second, the aperture on the other side of the forceps is slightly enlarged to permit the passage of a 3-mm (inner) diameter biopsy punch. The adjustment screw holds grip tension, thus allowing for greater mobility of the surgeon's off-hand.
Charcoal filters appropriate for isoflurane anesthesia waste gas scavenging 
Surgical suite
The space requirements for a surgical suite are not large, but the physical layout does require careful organization. We suggest a total of five stations be set up. First, the "preprocedure station" houses mice before the start of the procedure. Second, an anesthetic "induction station" includes materials for the initial administration of anesthesia to the animal (anesthetic gas induction box or materials for injectable anesthetics). Third, the "prep station" includes materials for fur removal (clippers and handheld vacuum) and application of disinfectant surgical scrub. Fourth, the "surgical station" includes a heated platform and bright lights as well as access to an array of sterile surgical implements. Finally, the "recovery station" includes a heated cage with clean, dry bedding for postprocedure recovery.
Suture (5-0 [silk/gut]) with needle Syringes (1 mL and 5 mL)
METHOD

Advance Preparation
Evaluate tumor location and anatomy.
At the most basic level, this may be accomplished through manual palpation. If available, preprocedure imaging can provide valuable information on the peri-tumoral anatomy and local vascularization ( Fig. 2A-C) . Imaging may also be used to evaluate the location of the biopsy following recovery of the animal from surgery ( Fig. 2D-F) . See Discussion for additional information.
2. Prepare Gelfoam coagulant plugs in advance of the surgical procedure. Perform this step in a Class II Biological Safety cabinet and wear fresh, sterile gloves. Keep sterile technique at all times.
i. Begin by cutting the Gelfoam sponge into 20-mm × 5-mm strips.
ii. Fold each strip in half longitudinally (to 10-mm length) and gently twist between thumb and index finger to form a tight cylindrical plug (Fig. 3A) .
iii. Store the plugs in individual sterile sachets. Do not autoclave the Gelfoam plugs or expose them to chemical disinfectant, as this will compromise their integrity.
3. Load a 5-mL syringe with sterile saline for wound bathing. 4. Load a 1-mL syringe (27-gauge needle) with the appropriate volume of working buprenorphine preparation.
The administration dose of buprenorphine is 0.1 mg/kg (or 120 µL of the 0.03-mg/mL preparation per 25 g of mouse).
Animal Preparation
5.
Prefill a sealed anesthesia induction chamber with 2% isoflurane in air (or oxygen).
6. Place the animal in the induction chamber until the animal shows no gross movement except for steady respiration. Confirm adequate anesthesia using the foot pad reflex test.
7.
Following initial induction, reduce the isoflurane concentration to 1.5%. Closely monitor the animal at all times and adjust the isoflurane concentration as needed to maintain appropriate plane of anesthesia. As the animal is moved between stations (induction, prep, or surgical), make certain to activate delivery of isoflurane to each new station and discontinue delivery of isoflurane to unused stations.
8.
Move the animal to the prep station. Using fine clippers, carefully shave the fur from a large field surrounding the planned incision site ( joint to armpit. After completion, use a handheld vacuum cleaner to collect and remove shaved fur from the Prep station, to minimize the spread of dander.
9. Apply a small amount of ophthalmic ointment to each eye to prevent dehydration.
10. Connect the biometric monitoring equipment to the animal.
11. Gently palpate the abdomen to confirm the location of the tumor and refine the location of the incision site.
12.
Prepare the left flank of the animal for surgery with a scrub using disinfectant applied with a soaked gauze or cotton tip applicator, followed by a similarly applied 70% alcohol scrub. Repeat the disinfectant/alcohol scrub procedure. Always begin the scrub process at the incision line and move outward to the shaved edge. Do not go over the incision site with the same scrub.
Surgery
See Troubleshooting.
13. Administer 0.1 mg/kg of 0.03 mg/mL buprenorphine intraperitoneal (i.p.) or subcutaneous (s.c.) as a postoperative analgesic.
Preemptive administration will give the agent time to take affect before the animal's recovery. 14. Use a scalpel or micro dissecting scissors to make a 15-mm longitudinal skin incision on the animal's left flank, centered on the latitude closest to the main tumor mass as determined by imaging and palpation (Fig. 3C ).
15. Gently blunt dissect subcutaneous fascia with scissors/forceps.
16. Use a scalpel or micro dissecting scissors to make a 12-mm longitudinal peritoneal incision within the area revealed by the skin incision (Fig. 3C) .
17. Use cotton tip applicators soaked in sterile saline to sponge and clean any minor wound bleeding.
18. Insert retractors into the wound and expand its edges outward to form a peritoneal opening 10 mm wide (Fig. 3D) .
19. Use micro dissecting forceps to carefully locate the tumor within the abdomen.
20. Isolate the tumor from the surrounding organs and tissues, taking care to avoid tearing or rupturing the connected tissues and vessels.
21. Expose the tumor via peritoneal opening and identify the target biopsy aperture (Fig. 3E) . Take care to displace the tumor mass as little as possible during this procedure.
22.
Use biopsy forceps to clamp the tumor by the axes of the target core, with the forceps aperture around one pole and the forceps plate at the opposite pole. Tighten the forceps screw to hold the tumor firmly in place (Fig. 3F ).
23. Insert the biopsy punch through the forceps aperture and push through with gentle twisting until the tool passes through the tumor to the forceps plate.
24. Twist the biopsy punch against the forceps plate to cut through the distal edge of the tumor core.
25.
Remove the biopsy punch and retrieve the core tissue sample (Fig. 3G) . Use a razor blade or scalpel blade on a glass plate to cut the sample as required. Treat the sample as per the required collection method (e.g., formalin, liquid nitrogen, OCT, RNAlater).
26.
Using micro dissecting forceps, insert a Gelfoam plug into the biopsy cavity (Fig. 3H) . Hold the plug in place until the Gelfoam has expanded to fill the cavity. Add further Gelfoam plugs if necessary. Use a sterile saline-soaked cotton tip applicator to apply pressure through the aperture of the biopsy forceps to staunch bleeding.
27. Gently loosen the biopsy forceps screw while continuing to apply pressure with the cotton tip applicator until excessive bleeding has stopped and the tumor can be fully released.
28. Use sterile gauze sponges to swab the peritoneal area to remove excess blood. Bathe the area in saline. Repeat swab.
29.
Release the retractors and gently replace the tumor within the abdominal space. 31. Remove and clean the biometric monitoring devices.
32.
Remove the animal from the operating stage and lay it on its right flank on gauze in a clean, heated recovery cage without other animals.
Postoperative Care
33. Monitor the animal closely and continuously until it regains consciousness and begins walking. Monitor for signs of respiratory distress (cyanosis, irregular, or labored breathing).
34. Administer 0.5 mL of saline i.p. if the animal has lost significant blood during the surgery or if it shows signs of dehydration postrecovery.
35.
Following initial recovery, monitor the animal frequently over successive days.
Continue postoperative analgesia as advised by veterinary staff.
A typical regimen is 0.1 mg/kg of buprenorphine, administered s.c. every 12 h for at least 2 d. Alternatively, 5 mg/kg of Carprofen may be administered s.c. daily.
TROUBLESHOOTING
Problem (Steps 13-32): It is difficult to maintain the animal's body temperature during surgery. Solution: Thermoregulation is a significant risk during any rodent surgical procedure. Use of a surgical platform that incorporates a temperature-controlled heating element allows for careful control of intraoperative body temperature. Make certain that the recovery cage is also appropriately warmed.
Problem (Steps 26-27): It is difficult to maintain hemostasis during the surgical procedure. Solution: The blood vessels surrounding a tumor are often very delicate and prone to rupture. Blood loss is the greatest risk in carrying out the surgical procedure. Care should be taken in accessing the tumor. Avoid sharp dissection of connective tissue surrounding the tumor; if access is difficult, try when possible to blunt dissection techniques. Attempt to displace the tumor from its native site as little as possible. Although Fig. 3 shows complete externalization of the tumor, it is not always necessary to do this. If it is possible to gain clear access to the tumor without externalizing, this may be preferable.
DISCUSSION
Translational cancer research is focused on the biology of tumors as they are perturbed by therapeutic agents. The dynamic response of tumors in the minutes, hours, days, and months after treatment provides important information about drug metabolism, mechanisms of action, determinants of primary drug sensitivity, and avenues of acquired drug resistance. One approach to studying these changes is to treat cohorts of animals with agents and controls in parallel and then collect tissues at a single, terminal time point. However, this single-time-point approach is predicated on the idea that the tumors arising in different animals are sufficiently similar that an effect between groups can be confidently detected with a manageable number of mice. In practice, the intertumoral heterogeneity apparent in most models is sufficiently high that only large effect sizes can be detected this way. Despite the uniformity of initiating mutations in a given cancer genetically engineered mouse model, secondary mutations will be acquired during tumor evolution that lead to at least some level of heterogeneity. Moreover, in certain models, particularly those incorporating engineered mutations that incur genomic instability (such as telomerase knockouts or point mutations in p53), inter-and intratumoral heterogeneity can be extremely high, making single-time-point approaches impractical. One way to mitigate the effects of intertumoral heterogeneity is to retrieve tissue samples from one tumor at multiple time points. For shallow tumors such as those of the skin or mammary glands, surgical procedures to acquire tissue samples are relatively minor. Conversely, tumors arising in the thoracic cavity or in the central nervous system are extremely challenging to access in a survival setting. However, for tumors in the abdominal cavity, tumor biopsies may be efficiently acquired by laparotomy, thereby enabling a full range of paired-sample study structures. The surgical approach taken to acquire tumor biopsies from different organs will vary in relation to the local tissue anatomy, local vascular anatomy, and the physiology of the organ.
Case Study: The KPC Model of Pancreatic Ductal Adenocarcinoma Some of the many considerations in designing a surgical approach for a specific tumor are illustrated here using the specific example of pancreatic tumors arising in the K-ras LSL.G12D/+ ; p53 LSL.R172H/+ ; Pdx1Cre tg/+ (KPC) mouse model (Hingorani et al. 2005) . This widely used model typically develops one or two discrete pancreatic tumors in the context of a preneoplastic pancreas. The suitability of pancreatic tumors for surgical biopsy is largely dependent on their precise location within the pancreas and their relationship to the surrounding vasculature and viscera. For example, tumors located in the head of the pancreas (HOP, on the animal's right side near the proximal duodenum) are often very difficult to biopsy because of their involvement with the duodenum, gallbladder, biliary tree, bowels, and/or retroperitoneal wall. Furthermore, these tumors are often situated near major vessels such as the aorta and vena cava and frequently invade around these structures. Apart from the challenge of isolating the tumor from these structures without tissue damage, identification of a suitable biopsy through the entire diameter of the tumor that avoids all major vessels can also be difficult. In contrast, tumors located in the tail of the pancreas (TOP, located near the spleen and left kidney) are often more amenable to surgical biopsy because this region of the pancreas is typically free of direct communication with other organs or major vessels. Although proximity to intestinal loops, the spleen, the left kidney, and the left uterine horn can complicate access, tumor isolation and core identification are significantly easier than for HOP lesions.
Evaluation of Tumor Location and Vascularity
A detailed understanding of the local tissue anatomy surrounding the site of tumor development and relevant vascular anatomy is required to plan a successful biopsy procedure. Some organs (liver, kidneys, adrenals, spleen, and ovaries) are relatively accessible, requiring only an appropriately situated peritoneal incision. However, deep organs such as the pancreas, prostate, and abdominal lymph nodes necessitate additional effort to access. Moreover, the anatomy of the tumor in relation to the remaining normal tissue of an organ also bears consideration. Tumors that extend into the lumen of an organ, such as the intestines, stomach, or bladder, are particularly challenging to access because of the need to maintain organ function and integrity. Finally, the vascular anatomy of the tumor has a critical impact on surgical outcome. Tumors often recruit new blood vessels from surrounding tissues or invade existing vessels. A poorly planned biopsy risks damage to these vessels and exsanguination.
The risk of damaging tissues and vessels can be mitigated through preprocedure imaging with a functional imaging modality that can identify vasculature. For pancreatic tumors, high-resolution ultrasound is a useful and accessible anatomical imaging technology (for a detailed protocol, see Sastra and Olive 2013) . Several types of functional ultrasound can provide additional information about blood flow. Color Doppler ultrasound is sensitive to the velocity and direction of blood flow, with red color indicating movement toward the transducer and blue color indicating flow away from the transducer ( Fig. 2A) . Power Doppler does not indicate directionality, but is more sensitive to smaller blood vessels (Fig. 2B ). In addition, contrast agents such as microbubbles (gas-filled liposomes) may be used to further highlight blood flow. Nonlinear contrast ultrasound allows the detection of contrast agents with little background signal from tissues and is the most sensitive of the three techniques for identifying small blood vessels and quantifying tissue perfusion (Fig. 2C) . Together, these three technologies have proven useful for the identification of relevant vessels during preprocedure screening.
Mouse Anesthesia
We strongly encourage the use of isoflurane gas as an anesthetic agent. Isoflurane is very well tolerated by mice. As a gas, it rapidly enters the system, resulting in quick induction upon exposure and a rapid recovery upon removal. The continuous administration of a rapidly cleared agent allows for much more subtle control of plane of anesthesia compared to injected agents. The use of isoflurane anesthetic requires attention to the design of both the gas delivery and waste removal systems. Isoflurane is a liquid at room temperature that is vaporized into a mixture with air or oxygen. Ideally, the surgical suite will have three stations that require anesthesia: an induction box for initial delivery of isoflurane to the mice, a prep station where the mice are shaved and prepared for the procedure, and the surgical station where procedures are performed. A fourth station for postoperative recovery is also necessary, but does not require access to anesthesia. To accommodate the need for anesthesia at multiple stations, we recommend the use of a vaporizer and anesthesia system with multiple independent circuits such that gas flow can be readily manipulated to each site (e.g., the VetEquip RC2 system). At each station, passive scavenging may be achieved through the use of charcoal canisters.
The sensitivity of different mice to anesthetics will range considerably based on variables such as strain background, age, and health status; tumor-bearing mice often have increased sensitivity to isoflurane. As a general guide, initial induction should be performed with 2% isoflurane gas, followed by maintenance at 1.5%. However, some animals will require as much as 2.75% isoflurane for induction or as low as 1% for maintenance. At all times, plane of anesthesia should be monitored through a combination of biophysical monitoring (pulse, heart rate, oximetry), foot pinch test, and direct observation of the animal. Veterinary staff should be consulted for appropriate training in the use of isoflurane anesthesia.
Outcome
Using the technique described above, core biopsies up to 3 mm in diameter may be acquired from mouse abdominal tumors, yielding up to 20 mg of tissue (Fig. 4A ). Samples may be divided longitudinally to provide half for histopathology (Fig. 4B,C) and the remainder for other molecular biology assays. The use of this biopsy surgery protocol enables the utilization of powerful paired-sample study structures that have the potential to significantly decrease the number of samples necessary to achieve appropriate statistical power. The Gelfoam plug inserted into the tumor is slowly absorbed over time. However, if it is still present at subsequent necropsy, the material may be sectioned and is easily identified histologically (Fig. 4D) . Local inflammation that may be apparent immediately adjacent to the plug should be taken into consideration when acquiring necropsy tissue samples for subsequent 
